世卫组织全球癌症临床试验格局
Raffaella Casolino1, Lambed Tatah2, Sarah Charnaud2
1Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland. casolinor@who.int.
Nature medicine
|September 9, 2025
概括
全球癌症临床试验不平等,高收入国家主导研究. 肝癌和胃癌等主要致命癌症的代表性不足,特别是在非洲和东南亚,阻碍了全球癌症控制工作.
科学领域:
- 在瘤学瘤学.
- 全球健康 全球健康
- 临床研究 临床研究
背景情况:
- 临床试验对于癌症控制至关重要,但面临着全球的获取和参与不平等.
- 世界卫生组织 (WHO) 国际临床试验注册平台 (ICTRP) 旨在提供临床研究的全面视图.
- 解决临床试验参与方面的差异对于公平的医疗保健结果至关重要.
研究的目的:
- 分析全球注册癌症临床试验的情况.
- 为了确定癌症临床试验注册,重点和合作的趋势.
- 在全球癌症研究中强调代表性不足的癌症类型和地理区域.
主要方法:
- 从1999年到2022年12月在世卫组织ICTRP注册的89,069项全球癌症临床试验的综合审查.
- 分析国家收入水平,干预类型和跨国合作的试验分布.
- 识别经常研究和代表性不足的癌症类型,重点关注地理差异.
主要成果:
- 全球癌症临床试验领域主要由高收入国家主导.
- 药理干预是主要重点,只有3%的试验涉及跨国合作.
- 致命的癌症 (肝脏,胃,胰腺,宫) 代表性不足,特别是在非洲和东南亚.
结论:
- 在全球癌症临床试验中存在显著的地理和癌症类型差异.
- 目前的试验分布没有充分解决某些致命癌症在低资源环境中的负担.
- 来自世卫组织ICTRP的数据可以为政策和投资提供信息,以促进公平的癌症研究和控制.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...


